Reply
We greatly appreciated Dr Jonas' interest in and comments on our recent study, and we thank him for sharing his experience in the treatment of complicated retinal arterial macroaneurysms with intravitreal bevacizumab. Dr Jonas raises an important point on the possible use of a single injection rather than a regimen of 3 injections, and we address his point herein. In addition to Dr Jonas’s study, the cases reported in literature base their anatomical and functional results on a mean of 2 intravitreal injections.